Elizabeth Swisher, MD of University of Washington Medical Center explains why it is crucial to use both germline and tumor testing instead of completely skipping germline testing. She states that if clinicians skip the initial germline testing, 10% of BRCA 1 mutations will be missed. This was recorded at the Society of Gynecologic Oncology (SGO)s Annual Meeting on Womens Cancer® in National Harbor, MD.
Importance of Paired Germline and Tumor Testing
